PMA device
Symplicity Spyral Multi-Electrode Renal Denervation Catheter
Medtronic, Inc. · Ablation Catheter, Renal Denervation (QYI, Class III) · First FDA decision Feb 15, 2024, newest Feb 15, 2024High blood pressure (hypertension)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
9
Naming "Symplicity Spyral Multi-Electrode"
MAUDE reports
0
Brand "Symplicity Spyral Multi-Electrode", since 2015
PubMed studies
0
Mentioning "Symplicity Spyral Multi-Electrode"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Symplicity Spyral Multi-Electrode Renal Denervation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Symplicity G3 Renal Devervation RF GeneratorPMA supplement
P220026-S001 · Decided Feb 15, 2024 · 59 days after receipt · Normal 180 Day Track No User Fee
Device type: Ablation catheter, renal denervation (QYI) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Renal Denervation for Uncontrolled HypertensionNational analysisReview closedCAG-00470NUpdated Sep 22, 2026
- Renal Denervation (RDN) for Uncontrolled HypertensionNational determinationOn the books20.40Updated Mar 24, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Symplicity Spyral Multi-Electrode", any status and sponsor, newest update first.
Medtronic VascularPublic (MDT)
NCT07174622 · 1,000 participants (planned) · Start Oct 28, 2025 · Primary completion Jun 2029
Device: Renal Denervation (Symplicity Spyral™) · For: Hypertension; Cardiovascular Diseases; Vascular Diseases
Sites: Boston, Massachusetts
- SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNActive, not recruiting
Medtronic VascularPublic (MDT)
NCT05198674 · 1,899 participants · Start Oct 20, 2021 · Primary completion Mar 5, 2026
Device: Renal Denervation (Symplicity Spyral™) · For: Hypertension; Vascular Diseases; Cardiovascular Diseases and 2 more
Sites: Birmingham, Alabama; Mesa, Arizona; Phoenix, Arizona · 97 sites in all
Medtronic VascularPublic (MDT)
NCT07115953 · 130 participants (planned) · Start Sep 22, 2025 · Primary completion Oct 30, 2027
Device: Symplicity Spyral™ multi-electrode renal denervation system · For: Hypertension; Vascular Diseases; Cardiovascular Diseases and 2 more
Sites: Melbourne, Australia; Perth, Australia; Genk, Belgium · 21 sites in all
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Symplicity Spyral Multi-Electrode", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QYI
47 reports: 13 malfunction, 33 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Symplicity Spyral Multi-Electrode"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QYI.
- Symplicity Spyral Renal Denervation SystemMedtronic, Inc. · PMA 2026
- Paradise Ultrasound Renal Denervation System (Paradise System)Recor Medical, Inc. · PMA 2026
- Symplicity G3 Renal Denervation RF GeneratorMedtronic, Inc. · PMA 2025
- ReCor Paradise® Ultrasound Renal Denervation SystemRecor Medical, Inc. · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.